Helius Therapeutics has become the first New Zealand company to gain approval from Medsafe to begin manufacturing medicinal cannabis. Chief quality officer Bruce Wallace said there would be ongoing auditing, and while it had the licence to manufacture, it still needed to meet minimum quality standards, through batch testing, by the Medicinal Cannabis Agency. READ MORE:* Inside the race to be NZ's first approved medicinal cannabis manufacturer* Tens of millions of dollars... still no local medicinal cannabis industry. About 40 licences have been granted to researchers, developers, and growers, following the enactment of the Medicinal Cannabis Scheme in April 2020. All of us at Helius Therapeutics, Medsafe, the Medicinal Cannabis Agency, and the wider industry are working incredibly hard to make that happen.”

Source: Stuff August 03, 2021 23:26 UTC